Skip to main content
ENSGThe Ensign Group, Inc.Buy Wait5.8·$182.21
Buy WaitModerate Confidence
Investment thesis

ENSG has beaten consensus four consecutive quarters and trades roughly 27% below the analyst-derived target of $191.75 with a risk/reward of approximately 3.9-to-1 in your favor, but a severe momentum breakdown — RSI at 25 with falling volume and confirming bearish technicals — and a pending legal news overhang argue for waiting until price stabilizes before establishing a position.

Thesis pillars

  • Four Consecutive Earnings Beats↓Deteriorating
  • Favorable Risk Reward Geometry→Stable
  • Momentum Breakdown Blocks Entry↑Improving
  • +1 more pillar — see the Why tab for full reasoning

Pillars as of Jul 3, 2026, based on the 10-K filed Feb 4, 2026· older than 90 days

Full reasoning →

Open full analysis

The Ensign Group, Inc. (ENSG) Stock Analysis

Momentum Cont setup

Buy WaitGrowthQualityAI GATE: FLAGGED — 2 risks, 1 concernModerate Confidence

Healthcare · Medical Care Facilities

Wait for pullback to $174.82. At $182.21 the A.R:R is 0.9:1 — below the 1.5:1 minimum for BUY_NOW. Engine's entry $174.82 (Ma50 Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Concentration risk — Product: skilled nursing facilities (95.6%); Thin upside margin: 6.8%.

The Ensign Group operates 373 skilled nursing and senior living facilities across 17 states, generating approximately 95.6% of revenue from skilled nursing. Revenue flows from Medicaid (45.8% of 2025 total revenue), Medicare (23.7% of service revenue), managed care, and private... Read more

$182.21+6.8% A.UpsideScore 5.8/10#18 of 35 Medical Care Facilities
QualityF-score6 / 9FCF yield3.50%
IncomeYield0.14%(5y avg 0.19%)Payout3.87%sustainable
Entry $174.82(Ma50 Sticky)Stop $163.38Target $194.53(analyst − 13%)A.R:R 0.9:1
Analyst consensus$223.60+22.7%5 analysts with price targets
$194.53our TP
$182.21price
$223.60mean
$240

Wait for pullback to $174.82. At $182.21 the A.R:R is 0.9:1 — below the 1.5:1 minimum for BUY_NOW. Engine's entry $174.82 (Ma50 Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Concentration risk — Product: skilled nursing facilities (95.6%); Thin upside margin: 6.8%. Chart setup: Trend continuation, RSI 56, MACD bullish. Mixed signals. Hold existing position. | News modifier +2 (HOLD_IF_HOLDING → STRONG_BUY_WAIT) Score 5.8/10, moderate confidence.

Passes 7/9 gates (positive momentum, clean insider activity, no SEC red flags, news boost analyst 0.60, earnings proximity 92d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.

10-K grounded · weekly refresh

About The Ensign Group, Inc.

About The Ensign Group, Inc.

The Ensign Group operated 373 skilled nursing and senior living facilities with 37,911 operational skilled nursing beds across 17 states at December 31, 2025, generating approximately 95.6% of revenue from skilled nursing services. Medicaid accounted for 45.8% of 2025 total revenue—the largest single source—while Medicare contributed 23.7% of service revenue. Between January 2021 and December 2025, the company added 145 facilities and 14,739 operational skilled nursing beds through acquisition, bringing the cumulative total to 37,911 beds from 25,032 in 2021.

Ensign earns skilled services revenue from four payer channels—Medicaid (46.6% of skilled services revenue in 2025), Medicare (24.7%), managed care, and private pay—by operating high-acuity post-acute care facilities serving patients recovering from strokes, cardiovascular conditions, neurological disorders, and joint replacements. The Standard Bearer subsidiary owns 152 real estate properties under a captive REIT structure; 116 are leased to the company's own independent subsidiaries (eliminated in consolidation) while 37 are leased to third-party operators, contributing $19.3 million in non-eliminated rental revenue out of total rental revenues of $126.9 million in 2025. Senior living, mobile diagnostics, transportation, and other ancillary services together comprise approximately 4.6% of annual revenue. Ensign's Five-Star Quality Rating average across all facilities was 6.8% above the national average at December 2025.

Show full overview

Ensign's Medicaid dependency exposes the company to federal and state budget decisions that may alter reimbursement terms rapidly. The OBBB, signed into law July 4, 2025, imposed work requirements for Medicaid eligibility, mandated state eligibility redeterminations every six months rather than annually, and prohibited new provider taxes—removing a mechanism many states used to generate Medicaid funding. California, Texas, and Arizona are specifically named in the 10-K as states where budget reductions or delays could adversely affect net patient service revenue and profitability, representing a geographic concentration within an already Medicaid-dependent revenue model.

See also: Healthcare · Medical Care Facilities

From The Ensign Group, Inc.'s most recent 10-K filing, extracted June 10, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated Nov 3, 2026
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Feb 4, 202792d to earnings· next earnings call

Thesis

Rewards
Sector modifier (Healthcare): +0.5
Strong earnings beat streak (4/4)
Positive news sentiment (+1.00)
Risks
Concentration risk — Product: skilled nursing facilities (95.6%)
Thin upside margin: 6.8%
V7 low-quality RISK_OFF penalty: -0.5 (Q=4.4)

Key Metrics

P/E (TTM)27.1
P/E (Fwd)20.8
Mkt Cap$10.6B
EV/EBITDA20.0
Profit Mgn7.0%
ROE17.1%
Rev Growth14.5%
Beta0.65
Dividend0.14%
Analysts with ratings12

Quality Signals

Piotroski F6/9

Options Flow

P/C0.11bullish
IV40%normal
Max Pain$145-20.4% vs spot

Concentration Risks(10-K Item 1A)

  • HIGHProductskilled nursing facilities96%
    10-K Item 1: 'we generated approximately 95.6% of our revenue from our skilled nursing facilities'
  • MEDIUMCustomerMedicaid46%
    10-K Item 1A: 'Medicaid is our largest source of revenue, accounting for 45.8% and 46.0% of our revenue for the years ended December 31, 2025 and 2024, respectively'
  • LOWCustomerMedicare24%
    10-K Item 1A: 'We derived 23.7% and 24.9% of our service revenue from the Medicare programs for the years ended December 31, 2025 and 2024, respectively'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
1.8
Support Resistance
3.3
52w Position
6.7
GatesA.R:R 0.9 < 1.5@spotDeath cross (50MA < 200MA)Momentum 8.1>=5.5Insider activity: OKNo SEC red flagsNEWS BOOST ANALYST 0.60EARNINGS PROXIMITY 92d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARMomentum ContSuitability: Moderate
RSI
56 · Neutral
↑ 20D MA↑ 50D MA↑ 200D MADEATH CROSSSupport $168.43Resistance $189.00

Price Targets

$163
$175
$195
A.Upside+6.8%
A.R:R0.9:1

Position Sizing

ConvictionMedium conviction
Suggested %0.5%
Max %1%
RegimeRisk-Off

Risk Alerts

! News modifier +2: HOLD_IF_HOLDING → STRONG_BUY_WAIT
! asymmetry at 0.9 (below the engine's 1.5 threshold)@spot
! News gate: flagged (2 risks, 1 concerns)

Earnings

B
B
B
B
4/4 beats
Next Earnings2027-02-04 (92d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is ENSG stock a buy right now?

Wait for pullback to $174.82. At $182.21 the A.R:R is 0.9:1 — below the 1.5:1 minimum for BUY_NOW. Engine's entry $174.82 (Ma50 Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Concentration risk — Product: skilled nursing facilities (95.6%); Thin upside margin: 6.8%. Chart setup: Trend continuation, RSI 56, MACD bullish. Mixed signals. Hold existing position. | News modifier +2 (HOLD_IF_HOLDING → STRONG_BUY_WAIT) Target $194.53 (+6.8%), stop $163.38 (−11.5%), A.R:R 0.9:1. Score 5.8/10, moderate confidence.

What is the ENSG stock price target?

Take-profit target: $194.53 (+6.8% upside). Target $194.53 (+6.8%), stop $163.38 (−11.5%), A.R:R 0.9:1. Stop-loss: $163.38.

What are the risks of investing in ENSG?

Concentration risk — Product: skilled nursing facilities (95.6%); Thin upside margin: 6.8%; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.4).

Is ENSG overvalued or undervalued?

The Ensign Group, Inc. trades at a P/E of 27.1 (forward 20.8). TrendMatrix value score: 5.4/10. Verdict: Buy (Wait for Entry).

What do analysts say about ENSG?

12 analysts rate ENSG, with a consensus score of 4.2/5. 5 analysts publish price targets averaging $224.

What does The Ensign Group, Inc. do?The Ensign Group operates 373 skilled nursing and senior living facilities across 17 states, generating approximately...

The Ensign Group operates 373 skilled nursing and senior living facilities across 17 states, generating approximately 95.6% of revenue from skilled nursing. Revenue flows from Medicaid (45.8% of 2025 total revenue), Medicare (23.7% of service revenue), managed care, and private pay. The company also owns 158 real estate properties through its captive REIT subsidiary, Standard Bearer, generating $126.9 million in rental revenues in 2025.

Related stocks: AVAH (Aveanna Healthcare Holdings Inc) · THC (Tenet Healthcare Corporation) · ASTH (Astrana Health Inc.) · GRDN (Guardian Pharmacy Services, Inc) · CHE (Chemed Corp)
Home › Stocks › ENSG

Latest news

Latest News

GlobeNewswire7d agoRISKLegal
Morningstar1d agoRISKLegal
Https://www.dars.gov.et/5d agoCONCERN
Seeking Alpha98d agoEarnings
GlobeNewswire98d agoLegal
Simplywall.st98d ago
MSN189d ago
StockStory189d agoEarnings
Seeking Alpha7d agoEarnings
Simply Wall St7d ago
StocksToTrade7d agoEarnings
Stock Titan105d ago
GlobeNewswire105d ago
MarketBeat196d ago
GlobeNewswire14d agoLegal
Business Wire140d agoLegal
The National Law Review112d agoLegal
Insider Monkey154d agoEarnings
HarianBasis.co154d ago
MSN154d agoLeadership Change
Loading more...